Nuvigil and Glioblastoma - a phase IV clinical study of FDA data

Summary:

Glioblastoma is reported only by a few people who take Nuvigil.

The phase IV clinical study analyzes which people take Nuvigil and have Glioblastoma. It is created by eHealthMe based on reports of 20,963 people who have side effects while taking Nuvigil from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Oct, 01, 2022

20,963 people reported to have side effects when taking Nuvigil.
Among them, 3 people (0.01%) have Glioblastoma.


What is Nuvigil?

Nuvigil has active ingredients of armodafinil. It is often used in narcolepsy. eHealthMe is studying from 22,184 Nuvigil users for its effectiveness, alternative drugs and more.

What is Glioblastoma?

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans) is found to be associated with 470 drugs and 262 conditions by eHealthMe.

Number of Nuvigil and Glioblastoma reports submitted per year:

Could Nuvigil cause Glioblastoma?

Gender of people who have Glioblastoma when taking Nuvigil *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Glioblastoma when taking Nuvigil *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 33.33 %
  • 60+: 66.67 %

Common drugs people take besides Nuvigil *:

  1. Vimpat: 1 person, 33.33%
  2. Thalomid: 1 person, 33.33%
  3. Temodar: 1 person, 33.33%
  4. Subsys: 1 person, 33.33%
  5. Sancuso: 1 person, 33.33%
  6. Promethegan: 1 person, 33.33%
  7. Metformin: 1 person, 33.33%
  8. Lorazepam: 1 person, 33.33%
  9. Fluconazole: 1 person, 33.33%
  10. Famotidine: 1 person, 33.33%

Common side effects people have besides Glioblastoma *:

  1. Weakness: 2 people, 66.67%
  2. Fall: 2 people, 66.67%
  3. Vasogenic Cerebral Oedema (increase in brain water): 1 person, 33.33%
  4. Peritumoural Oedema (swelling from excessive accumulation of watery fluid in cells in peritumoural): 1 person, 33.33%
  5. Oedema (fluid collection in tissue): 1 person, 33.33%
  6. Malignant Neoplasm Progression (cancer tumour came back): 1 person, 33.33%
  7. Haemorrhage Intracranial (bleeding within the skull): 1 person, 33.33%
  8. Cerebral Thrombosis (blood clot in brain): 1 person, 33.33%
  9. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 33.33%

Common conditions people have *:

  1. Multiple Myeloma (cancer of the plasma cells): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nuvigil and have Glioblastoma?

Check whether Glioblastoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Glioblastoma and when was it recovered:

Expand to all the drugs that have ingredients of armodafinil:

Alternative drugs to, pros and cons of Nuvigil:

Common Nuvigil side effects:

Browse all side effects of Nuvigil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Glioblastoma treatments and more:

COVID vaccines that are related to Glioblastoma:

Common drugs associated with Glioblastoma:

All the drugs that are associated with Glioblastoma:

Common conditions associated with Glioblastoma:

All the conditions that are associated with Glioblastoma:

How the study uses the data?

The study uses data from the FDA. It is based on armodafinil (the active ingredients of Nuvigil) and Nuvigil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: